World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
11741
World Ranking
2328
National Ranking
174

Jean Rommelaere publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jean Rommelaere sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 302 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jean Rommelaere D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean Rommelaere sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jean Rommelaere is affiliated with the German Cancer Research Center in Germany, with a research focus primarily on virus-based gene therapy and cancer treatment strategies.

Their recent publications cover a range of topics related to oncolytic virotherapy, immune system activation, and cancer therapeutics. Notable papers include:

  • Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (2021, Clinical Cancer Research)
  • Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies (2021, Viruses)
  • Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers (2021, Cancers)
  • Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells (2023, Pathogens)
  • Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma (2021, Journal of Controlled Release)

Their work intersects several fields of study, predominantly:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

With specific subfields including genetics, oncology, animal science and zoology, infectious diseases, and molecular biology.

Key research topics Jean Rommelaere has contributed to are:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Animal Virus Infections Studies
  • Cutaneous lymphoproliferative disorders research
  • Parvovirus B19 Infection Studies
  • Viral-associated cancers and disorders
  • Cancer Research and Treatments

Frequent coauthors collaborating with Rommelaere include:

  • Assia L. Angelova
  • Guy Ungerechts
  • Jürg P. F. Nüesch
  • Barbara Leuchs
  • Christine E. Engeland

They have published in a variety of scientific journals, with multiple contributions to Pathogens and Cancers. Other publication venues include Clinical Cancer Research, Viruses, and Journal of Controlled Release.

Best Publications

  • Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

    Karsten Geletneky;Jacek Hajda;Assia L. Angelova;Barbara Leuchs

  • Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses.

    Jean Rommelaere;Douglas V. Faller;Nancy Hopkins

  • Antineoplasic activity of parvoviruses

    Jean Rommelaere;Jan J. Cornelis

  • Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

    Karsten Geletneky;Johannes Huesing;Jean Rommelaere;Joerg R Schlehofer

  • Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells

    Matteo Di Piazza;Carmen Mader;Karsten Geletneky;Marta Herrero Y Calle

  • Oncolytic parvoviruses as cancer therapeutics.

    Jean Rommelaere;Karsten Geletneky;Assia L. Angelova;Assia L. Angelova;Laurent Daeffler

  • Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune Response In Vitro via Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic Cells

    Markus H. Moehler;Maja Zeidler;Vanessa Wilsberg;Jan J. Cornelis

  • Induction of Programmed Cell Death by Parvovirus H-1 in U937 Cells: Connection with the Tumor Necrosis Factor Alpha Signalling Pathway

    Béatrice Rayet;José Antonio Lopez-Guerrero;José Antonio Lopez-Guerrero;Jean Rommelaere;Christiane Dinsart

  • Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

    Assia L. Angelova;Marc Aprahamian;Svitlana P. Grekova;Amor Hajri

  • NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp

    Anne-Nicole Brandenburger;Daniel Legendre;Bernard Avalosse;Jean Rommelaere

  • cis Requirements for the Efficient Production of Recombinant DNA Vectors Based on Autonomous Parvoviruses

    Jurgen Kestler;Bernd Neeb;Sofie Struyf;Jo Van Damme

  • Molecular Pathways: Rodent Parvoviruses—Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment

    Jürg P.F. Nüesch;Jeannine Lacroix;Antonio Marchini;Jean Rommelaere

  • Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.

    Stephen Russell;Anne-Nicole Brandenburger;Claudia C.L. Flemming;Mary K L Collins

  • A model for tumor suppression using H-1 parvovirus.

    Adam Telerman;Marcel Tuynder;Thierry Dupressoir;Bernard Robaye

  • Through Its Nonstructural Protein NS1, Parvovirus H-1 Induces Apoptosis via Accumulation of Reactive Oxygen Species

    Georgi Hristov;Melanie Krämer;Junwei Li;Nazim El-Andaloussi

  • TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma.

    M Enderlin;Ev Kleinmann;S Struyf;C Buracchi

  • Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

    Karsten Geletneky;Irina Kiprianova;Irina Kiprianova;Ali Ayache;Regina Koch;Regina Koch

  • Inhibition by Parvovirus H-1 of the Formation of Tumors in Nude Mice and Colonies in Vitro by Transformed Human Mammary Epithelial Cells

    Thierry Dupressoir;Jean-Marc Vanacker;Jan J. Cornelis;Jan J. Cornelis;Nadine Duponchel

  • Oncolytic parvoviruses: from basic virology to clinical applications

    Antonio Marchini;Serena Bonifati;Eleanor M Scott;Assia L Angelova

  • Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses.

    Guy Ungerechts;Sascha Bossow;Barbara Leuchs;Per S Holm

  • Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice

    J. J. Cornelis;P. Becquart;N. Duponchel;N. Salome

  • Identification of a Novel Cellular TPR-Containing Protein, SGT, That Interacts with the Nonstructural Protein NS1 of Parvovirus H-1

    Celina Cziepluch;Elisabeth Kordes;Rémy Poirey;Annabel Grewenig

Frequent Co-Authors

Sofie Struyf
Sofie Struyf KU Leuven
Thomas Giese
Thomas Giese Heidelberg University
Silvano Sozzani
Silvano Sozzani Sapienza University of Rome
A. J. Van Der Eb
A. J. Van Der Eb Leiden University
Aurora Pujol
Aurora Pujol Institut d'Investigació Biomédica de Bellvitge
Douglas V. Faller
Douglas V. Faller Takeda (Japan)
Annunciata Vecchi
Annunciata Vecchi Mario Negri Institute for Pharmacological Research
Peter Tattersall
Peter Tattersall Yale University
Jo Van Damme
Jo Van Damme Rega Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, many of which can be enhanced with additional online credentials. For those interested in healthcare data management, exploring the best cahiim accredited him programs online is a smart step. These programs ensure graduates are well-prepared to handle medical records and health information systems effectively.

If you prefer a focused and accelerated path, consider earning an accelerated medical billing and coding certificate online. This is ideal for individuals who want to quickly enter the healthcare industry with specialized coding skills that are in high demand.

For those interested in expanding clinical knowledge alongside microbiology, numerous medical programs online offer degrees tailored to various healthcare careers. These programs provide flexibility and access to quality education without the need to attend on-campus classes.

Additionally, pursuing a public health degree is a valuable option. Many accredited institutions feature accredited online mph programs easy to get into, allowing students to broaden their expertise in health policy, epidemiology, and community health while balancing other commitments.

Best Scientists Citing Jean Rommelaere

Trending Scientists

Recently Published Articles